Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves
CIPROFLOXACIN;
DRUG METABOLITE;
ENROCIN;
ENROFLOXACIN;
ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
ANALYTIC METHOD;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
BUFFALO;
CONTROLLED STUDY;
DRUG ADMINISTRATION ROUTE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
SINGLE DRUG DOSE;
ANIMAL;
ANIMAL DISEASE;
BLOOD;
HALF LIFE TIME;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
ANIMALIA;
BUBALUS;
ANIMALS;
ANTI-INFECTIVE AGENTS;
AREA UNDER CURVE;
BUFFALOES;
CIPROFLOXACIN;
FLUOROQUINOLONES;
HALF-LIFE;
INJECTIONS, INTRAMUSCULAR;
INJECTIONS, INTRAVENOUS;
MALE;
QUINOLONES;
Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens
Bugyei K. Black W.D. McEwen S. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens Canadian Journal of Veterinary Research. 63 1999 193-207
Pharmacokinetics of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7- (4-ethyl-1-piperazinyl)-3 quinolone-carboxylic acid (CFPQ) in pre-ruminant and ruminant calves
Davidson J.N. Conzelman G.M. Baggot J.D. Pharmacokinetics of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3 quinolone-carboxylic acid (CFPQ) in pre-ruminant and ruminant calves Proceedings of the Western Pharmacological Society 29 1986 129-132
Pharmacodynamics of a fluoroquinolone antimicrobial agents in a neutropenic rat model of Pseudomonas species
Drusano G.L. Johnson D.E. Rosen M. Pharmacodynamics of a fluoroquinolone antimicrobial agents in a neutropenic rat model of Pseudomonas species Antimicrobial Agents Chemotherapy 37 1993 483-490
Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones
Dudley M.N. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones The American Journal of Veterinary Medicine 91 1991 455-505
Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cattle
Kaartinen L. Salonen M. Alli L. Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cattle Journal of Veterinary Pharmacology and Therapeutics 18 1995 357-362
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs
Kung K. Riond J.L. Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs Journal of Veterinary Pharmacology and Therapeutics 16 1993 462-468
Disposition of enrofloxacin (Baytril)™ into the udder after intravenous and intra-arterial injections into dairy cows
Malbe M. Salonen M. Fang W. Oopik T. Jalakas M. Klassen M. Sandholm M. Disposition of enrofloxacin (Baytril)™ into the udder after intravenous and intra-arterial injections into dairy cows Journal of Veterinary Medicine A43 1996 377-386
In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin
Prescott J. Yielding K.H. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin Canadian Journal of Veterinary Research 54 1990 195-197